{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:55:59Z","timestamp":1712343359799},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,1,6]],"date-time":"2002-01-06T00:00:00Z","timestamp":1010275200000},"content-version":"vor","delay-in-days":1315,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>SummaryA population dynamic model of schistosome transmission was used to investigate the interaction between drug efficacy and drug price of different brands of praziquantel in determining the cost\u2010effectiveness of school\u2010targeted treatment for Schistosoma mansoni. In this analysis, costs were affected by coverage, drug price and distance travelled, and effectiveness by coverage and drug efficacy. Four effectiveness measures were assessed: the number of infection case\u2010years prevented, heavy infection case\u2010years prevented, hepatomegaly case\u2010years prevented and fibrosis case\u2010years prevented. The interactions between drug efficacy and drug price were complex. In particular, there was a highly nonlinear relationship between drug efficacy and cost\u2010effectiveness, with drugs of low efficacy producing high and variable cost\u2010effectiveness ratios, particularly when other programme costs related to distance travelled were high. The results suggest that given the current price range of praziquantel, a drug with less than a 50% chance of killing the worms is not to be recommended. This has important practical implications for the widespread use of praziquantel, since most international agencies procure praziquantel purely on the basis of price. There is clearly a need for studies which evaluate the efficacy of new brands of praziquantel, and more credence should be given to the use of high efficacy brands, not only in terms of maximizing the cost\u2010effectiveness of the intervention programme, but also in delaying the onset of drug resistance.<\/jats:p>","DOI":"10.1046\/j.1365-3156.1998.00248.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:31:22Z","timestamp":1047504682000},"page":"425-435","source":"Crossref","is-referenced-by-count":12,"title":["An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost\u2010effectiveness of school\u2010targeted treatment for <i>Schistosoma mansoni<\/i> using a population dynamic model"],"prefix":"10.1111","volume":"3","author":[{"given":"Helen L.","family":"Guyatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man\u2010Suen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/297557a0"},{"key":"e_1_2_6_3_2","unstructured":"Infectious diseases of humans:dynamics and controlOxford University Press Oxford."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(97)01144-7"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000078422"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800058453"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1996.55.52"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(96)00039-3"},{"key":"e_1_2_6_9_2","unstructured":"Methods for the economic evaluation of health care programmes. Oxford University Press Oxford."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/9.4.385"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90638-X"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-6618(95)80048-4"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000075016"},{"key":"e_1_2_6_14_2","unstructured":"Effectiveness and costs of integrated schistosomiasis control: an example of the Bandiagara District Republic of Mali. MBA thesis School of Management and health Economics Keele University."},{"key":"e_1_2_6_15_2","unstructured":"Disease Control Priorities in Developing Countries(eds. DT Jamison WH Mosley AR Measham & JL Bobadilla) Oxford University Press Oxford. pp. 131\u2013160."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(92)90076-A"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1992.tb00029.x"},{"key":"e_1_2_6_18_2","unstructured":"World Development Report: Investing in Health. Oxford University Press Oxford."},{"key":"e_1_2_6_19_2","unstructured":"World Health Organization (1985) The Control of Schistosomiasis. Report of an Expert Committee. Technical Report Series no. 728. World Health Organization Geneva."},{"key":"e_1_2_6_20_2","unstructured":"World Health Organization (1993)The Control of Schistosomiasis. Second Report of an Expert Committee. Technical Report Series no. 830. World Health Organization Geneva."}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.1998.00248.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.1998.00248.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-3156.1998.00248.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.1998.00248.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T09:35:45Z","timestamp":1694338545000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.1998.00248.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1046\/j.1365-3156.1998.00248.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.1998.00248.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}